Integra LifeSciences Holdings Corporation (IART) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Integra LifeSciences Holdings Corporation (IART:NASDAQ), powered by AI.

Current Price
$17.71
P/E Ratio
-2.6
Market Cap
1.4B
Sector
Healthcare
What is the Integra LifeSciences Holdings Corporation stock price forecast?

Integra LifeSciences Holdings Corporation is currently trading at $17.71. View real-time AI analysis on Alpha Lenz.

What is Integra LifeSciences Holdings Corporation insider trading activity?

View the latest insider trading data for Integra LifeSciences Holdings Corporation on Alpha Lenz.

What is Integra LifeSciences Holdings Corporation's P/E ratio?

Integra LifeSciences Holdings Corporation's P/E ratio is -2.6.

Integra LifeSciences Holdings Corporation

NASDAQ · IART
$17.71+0.25(+1.43%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Integra LifeSciences Holdings Corporation's future dividend policy...
Alpha Chat Insight

Integra LifeSciences Holdings Corporation trades at a P/E of -2.6 (undervalued) with modest ROE of -39.9%.

Ask for details

Company Overview

Integra LifeSciences Holdings Corporation is a prominent company in the medical device field, focused on providing innovative solutions for patients and healthcare professionals globally. Known for its comprehensive portfolio, Integra LifeSciences develops, manufactures, and markets medical devices used primarily in neurosurgery, reconstructive surgery, and regenerative medicine. The company's offerings include a variety of implants, devices, and instruments designed to improve surgical procedures and outcomes. Integra LifeSciences serves multiple sectors within the healthcare industry, including hospitals, surgical centers, and rehabilitation facilities. The organization's commitment to advancing medical technology positions it as a critical player in enhancing patient care and driving medical advancements. Founded in 1989, Integra LifeSciences has established a significant presence in both domestic and international markets, continually striving to innovate and improve the quality of life for patients worldwide. Its role in the healthcare sector underscores the importance of technological development in medical applications, impacting numerous lives through its research and development efforts.

CEOMs. Mojdeh Poul
SectorHealthcare
IndustryMedical Devices
Employees4,396

Company Statistics

FY 2025

Profile

$1.36BMarket Cap
$1.64BRevenue
0.00Shares Out
4,396Employees

Margins

50.86%Gross
11.37%EBITDA
1.10%Operating
-34.46%Pre-Tax
-31.58%Net

Valuation

-2.63P/E
1.30P/B
0.83EV/Sales
16.97EV/EBITDA
-30.01P/FCF

Growth (CAGR)

1.63%Rev 3Yr
3.57%Rev 5Yr
-57.77%Op Inc 3Yr
-34.68%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-13.52%ROA
-39.90%ROE
-12.49%ROIC

Financial Health

$235.05MCash & Cash Equivalents
$2.32BNet Debt
245.20%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Integra LifeSciences Holdings Corporation (ticker: IART) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 4,396 employees. Market cap is $1.4B.

The current price is $17.71 with a P/E ratio of -2.63x and P/B of 1.3x.

ROE is -39.90% and operating margin is 1.10%. Annual revenue is $1.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Integra LifeSciences Holdings Corporation (IART) Stock Forecast 2026 $17.71 — Price, Financials & Analyst Targets | Alpha Lenz